BridgeMD
Compares treatment options for Electrical Impedance Tomography (EIT)
Official title EIT-guided PEEP Titration Versus Standard Ventilation in Bariatric Surgery
ClinicalTrials.gov ID: NCT07207772
What this study is testing
- What it's testing
- This study is a prospective, single-center, single-blind, randomized controlled clinical trial. Patients scheduled for laparoscopic bariatric surgery will be selected and randomly assigned to either the EIT-guided individualized PEEP group (Group P-eit) or the control group (Group P-8).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65 years;
- Plan to receive laparoscopic bariatric surgery under general anesthesia;
- American Society of Anaesthesiologists (ASA) physical status I-III;
- BMI between 30 and 55 kg/m2;
- Voluntary participation in this study and signing of an informed consent form.
You likely can't join if
- History of smoking or previous thoracic surgery;
- Invasive mechanical ventilation within 30 days;
- Pregnancy;
- Allergy to EIT electrodes;
- Persistent hemodynamic instability or refractory shock;
- Severe cardiopulmonary disease (e.g., severe COPD (Chronic obstructive pulmonary disease), NYHA (New York Heart Association) Class III or IV, acute...
See the full eligibility criteria
- Age between 18 and 65 years;
- Plan to receive laparoscopic bariatric surgery under general anesthesia;
- American Society of Anaesthesiologists (ASA) physical status I-III;
- BMI between 30 and 55 kg/m2;
- Voluntary participation in this study and signing of an informed consent form.
- History of smoking or previous thoracic surgery;
- Invasive mechanical ventilation within 30 days;
- Pregnancy;
- Allergy to EIT electrodes;
- Persistent hemodynamic instability or refractory shock;
- Severe cardiopulmonary disease (e.g., severe COPD (Chronic obstructive pulmonary disease), NYHA (New York Heart Association) Class III or IV, acute coronary syndrome, or sustained ventricular tachycardia);
- Severe pulmonary hypertension (systolic pulmonary artery pressure \>40 mmHg);
- Increased intracranial pressure, intracranial injury/tumor, or neuromuscular disorders;
- Conversion to laparotomy;
- Planned transfer to intensive care unit after surgery.
The study team makes the final eligibility decision.
Where it's taking place
- Jinan, Shandong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jinan, Shandong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.